A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture
ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions within just a few months, causing severe respiratory disease and mortality. Assays to monitor SARS-CoV-2 growth in vitro depend on time-consuming and costly RNA extraction steps, hampering progress in basic r...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
American Society for Microbiology
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/5fa8bcf9f0bd472e90df2dc12e6e4f5e |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:5fa8bcf9f0bd472e90df2dc12e6e4f5e |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:5fa8bcf9f0bd472e90df2dc12e6e4f5e2021-11-15T15:30:59ZA Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture10.1128/mSphere.00658-202379-5042https://doaj.org/article/5fa8bcf9f0bd472e90df2dc12e6e4f5e2020-10-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSphere.00658-20https://doaj.org/toc/2379-5042ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions within just a few months, causing severe respiratory disease and mortality. Assays to monitor SARS-CoV-2 growth in vitro depend on time-consuming and costly RNA extraction steps, hampering progress in basic research and drug development efforts. Here, we developed a simplified quantitative real-time PCR assay that bypasses viral RNA extraction steps and can monitor SARS-CoV-2 growth from a small amount of cell culture supernatants. In addition, we show that this approach is easily adaptable to numerous other RNA and DNA viruses. Using this assay, we screened the activities of a number of compounds that were predicted to alter SARS-CoV-2 entry and replication as well as HIV-1-specific drugs in a proof-of-concept study. We found that E64D (inhibitor of endosomal proteases cathepsin B and L) and apilimod (endosomal trafficking inhibitor) potently decreased the amount of SARS-CoV-2 RNA in cell culture supernatants with minimal cytotoxicity. Surprisingly, we found that the macropinocytosis inhibitor ethylisopropylamiloride (EIPA) similarly decreased SARS-CoV-2 RNA levels in supernatants, suggesting that entry may additionally be mediated by an alternative pathway. HIV-1-specific inhibitors nevirapine (a nonnucleoside reverse transcriptase inhibitor [NNRTI]), amprenavir (a protease inhibitor), and allosteric integrase inhibitor 2 (ALLINI-2) modestly inhibited SARS-CoV-2 replication, albeit the 50% inhibitory concentration (IC50) values were much higher than that required for HIV-1. Taking the data together, this simplified assay will expedite basic SARS-CoV-2 research, be amenable to mid-throughput screening assays (i.e., drug, CRISPR, small interfering RNA [siRNA], etc.), and be applicable to a broad number of RNA and DNA viruses. IMPORTANCE Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of the coronavirus disease 2019 (COVID-19) pandemic, is continuing to cause immense respiratory disease and social and economic disruptions. Conventional assays that monitor SARS-CoV-2 growth in cell culture rely on costly and time-consuming RNA extraction procedures, hampering progress in basic SARS-CoV-2 research and development of effective therapeutics. Here, we developed a simple quantitative real-time PCR assay to monitor SARS-CoV-2 growth in cell culture supernatants that does not necessitate RNA extraction and that is as accurate and sensitive as existing methods. In a proof-of-concept screen, we found that E64D, apilimod, EIPA, and remdesivir can substantially impede SARS-Cov-2 replication, providing novel insight into viral entry and replication mechanisms. In addition, we show that this approach is easily adaptable to numerous other RNA and DNA viruses. This simplified assay will undoubtedly expedite basic SARS-CoV-2 and virology research and be amenable to use in drug screening platforms to identify therapeutics against SARS-CoV-2.Christian Shema MugishaHung R. VuongMaritza Puray-ChavezAdam L. BaileyJulie M. FoxRita E. ChenAlex W. WesselJason M. ScottHouda H. HarastaniAdrianus C. M. BoonHaina ShinSebla B. KutluayAmerican Society for MicrobiologyarticleSARS-CoV-2antiviralsassay developmentviral entryvirus replicationMicrobiologyQR1-502ENmSphere, Vol 5, Iss 5 (2020) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
SARS-CoV-2 antivirals assay development viral entry virus replication Microbiology QR1-502 |
| spellingShingle |
SARS-CoV-2 antivirals assay development viral entry virus replication Microbiology QR1-502 Christian Shema Mugisha Hung R. Vuong Maritza Puray-Chavez Adam L. Bailey Julie M. Fox Rita E. Chen Alex W. Wessel Jason M. Scott Houda H. Harastani Adrianus C. M. Boon Haina Shin Sebla B. Kutluay A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture |
| description |
ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions within just a few months, causing severe respiratory disease and mortality. Assays to monitor SARS-CoV-2 growth in vitro depend on time-consuming and costly RNA extraction steps, hampering progress in basic research and drug development efforts. Here, we developed a simplified quantitative real-time PCR assay that bypasses viral RNA extraction steps and can monitor SARS-CoV-2 growth from a small amount of cell culture supernatants. In addition, we show that this approach is easily adaptable to numerous other RNA and DNA viruses. Using this assay, we screened the activities of a number of compounds that were predicted to alter SARS-CoV-2 entry and replication as well as HIV-1-specific drugs in a proof-of-concept study. We found that E64D (inhibitor of endosomal proteases cathepsin B and L) and apilimod (endosomal trafficking inhibitor) potently decreased the amount of SARS-CoV-2 RNA in cell culture supernatants with minimal cytotoxicity. Surprisingly, we found that the macropinocytosis inhibitor ethylisopropylamiloride (EIPA) similarly decreased SARS-CoV-2 RNA levels in supernatants, suggesting that entry may additionally be mediated by an alternative pathway. HIV-1-specific inhibitors nevirapine (a nonnucleoside reverse transcriptase inhibitor [NNRTI]), amprenavir (a protease inhibitor), and allosteric integrase inhibitor 2 (ALLINI-2) modestly inhibited SARS-CoV-2 replication, albeit the 50% inhibitory concentration (IC50) values were much higher than that required for HIV-1. Taking the data together, this simplified assay will expedite basic SARS-CoV-2 research, be amenable to mid-throughput screening assays (i.e., drug, CRISPR, small interfering RNA [siRNA], etc.), and be applicable to a broad number of RNA and DNA viruses. IMPORTANCE Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of the coronavirus disease 2019 (COVID-19) pandemic, is continuing to cause immense respiratory disease and social and economic disruptions. Conventional assays that monitor SARS-CoV-2 growth in cell culture rely on costly and time-consuming RNA extraction procedures, hampering progress in basic SARS-CoV-2 research and development of effective therapeutics. Here, we developed a simple quantitative real-time PCR assay to monitor SARS-CoV-2 growth in cell culture supernatants that does not necessitate RNA extraction and that is as accurate and sensitive as existing methods. In a proof-of-concept screen, we found that E64D, apilimod, EIPA, and remdesivir can substantially impede SARS-Cov-2 replication, providing novel insight into viral entry and replication mechanisms. In addition, we show that this approach is easily adaptable to numerous other RNA and DNA viruses. This simplified assay will undoubtedly expedite basic SARS-CoV-2 and virology research and be amenable to use in drug screening platforms to identify therapeutics against SARS-CoV-2. |
| format |
article |
| author |
Christian Shema Mugisha Hung R. Vuong Maritza Puray-Chavez Adam L. Bailey Julie M. Fox Rita E. Chen Alex W. Wessel Jason M. Scott Houda H. Harastani Adrianus C. M. Boon Haina Shin Sebla B. Kutluay |
| author_facet |
Christian Shema Mugisha Hung R. Vuong Maritza Puray-Chavez Adam L. Bailey Julie M. Fox Rita E. Chen Alex W. Wessel Jason M. Scott Houda H. Harastani Adrianus C. M. Boon Haina Shin Sebla B. Kutluay |
| author_sort |
Christian Shema Mugisha |
| title |
A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture |
| title_short |
A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture |
| title_full |
A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture |
| title_fullStr |
A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture |
| title_full_unstemmed |
A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture |
| title_sort |
simplified quantitative real-time pcr assay for monitoring sars-cov-2 growth in cell culture |
| publisher |
American Society for Microbiology |
| publishDate |
2020 |
| url |
https://doaj.org/article/5fa8bcf9f0bd472e90df2dc12e6e4f5e |
| work_keys_str_mv |
AT christianshemamugisha asimplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT hungrvuong asimplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT maritzapuraychavez asimplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT adamlbailey asimplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT juliemfox asimplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT ritaechen asimplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT alexwwessel asimplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT jasonmscott asimplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT houdahharastani asimplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT adrianuscmboon asimplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT hainashin asimplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT seblabkutluay asimplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT christianshemamugisha simplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT hungrvuong simplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT maritzapuraychavez simplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT adamlbailey simplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT juliemfox simplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT ritaechen simplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT alexwwessel simplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT jasonmscott simplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT houdahharastani simplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT adrianuscmboon simplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT hainashin simplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture AT seblabkutluay simplifiedquantitativerealtimepcrassayformonitoringsarscov2growthincellculture |
| _version_ |
1718427827053789184 |